Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
Lorant T, Bengtsson M, Eich T, Eriksson BM, Winstedt L, Järnum S, Stenberg Y, Robertson AK, Mosén K, Björck L, Bäckman L, Larsson E, Wood K, Tufveson G, Kjellman C.
Lorant T, et al. Among authors: jarnum s.
Am J Transplant. 2018 Nov;18(11):2752-2762. doi: 10.1111/ajt.14733. Epub 2018 Apr 17.
Am J Transplant. 2018.
PMID: 29561066
Free PMC article.
Clinical Trial.